Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/ N rats

Toxicological Sciences

Volumn 97, Issue 2, 2007, Pages 288-298

  Rached, Eva ^a   Hard, Gordon C ^b   Blumbach, Kai ^a   Weber, Klaus ^a   Draheim, Regina ^a   Lutz, Werner K ^a   Özden, Sibel ^a   Steger, Ulrich ^c   Dekant, Wolfgang ^a   Mally, Angela ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b RCC Ltd ^*

^c RCC Ltd   (Switzerland)

Author keywords

Carcinogenicity; Cell proliferation; Karyomegaly; Kidney; Ochratoxin A

Indexed keywords

BROXURIDINE; OCHRATOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CARCINOGEN TESTING; CARCINOGENESIS; CARCINOGENICITY; CELL DEATH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPIGENETICS; FISCHER 344 RAT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PROXIMAL TUBULE; KIDNEY TUMOR; MALE; NONHUMAN; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIMETABOLITES; BLOOD CELL COUNT; BODY WEIGHT; BROMODEOXYURIDINE; CARCINOGENS; CELL PROLIFERATION; KIDNEY; LIVER; MALE; OCHRATOXINS; ORGAN SIZE; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS;

EID: 34447551596     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm042     Document Type: Article

References (40)

1. Alden, C. L. (2000). Safety assessment for non-genotoxic rodent carcinogens: Curves, low-dose extrapolations, and mechanisms in carcinogenesis. Hum. Exp. Toxicol. 19, 557-560; discussion 571-552.
2. Benesic, A., Mildenberger, S., and Gekle, M. (2000). Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells. Pflugers Arch. 439, 278-287.
3. Boorman, G. A., McDonald, M. R., Imoto, S., and Persing, R. (1992). Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 20, 236-245.
4. Butterworth, B. E., and Bogdanffy, M. S. (1999). A comprehensive approach for integration of toxicity and cancer risk assessments. Regul. Toxicol. Pharmacol. 29, 23-36.
5. Cavin, C., Delatour, T., Marin-Kuan, M., Holzhauser, D., Higgins, L., Bezencon, C., Guignard, G., Junod, S., Piguet, D., Richoz-Payot, J., et al. (2007). Reduction in antioxidant defences may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol. Sci. 96, 30-39.
6. Dietrich, D. R., and Swenberg, J. A. (1991a). Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: Predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat. Res. 248, 239-260.
7. Dietrich, D. R., and Swenberg, J. A. (1991b). The presence of alpha 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res. 51, 3512-3521.
8. Dill, J.A., Lee,K.M., Renne,R.A., Miller, R.A., Fuciarelli,A. F.,Gideon,K.M., Chan, P. C., Burka, L. T., and Roycroft, J. H. (2003). Alpha 2u-globulin nephropathy and carcinogenicity following exposure to decalin (decahydronaphthalene) in F344/N rats. Toxicol. Sci. 72 223-234.
9. Dopp, E., Muller, J., Hahnel, C., and Schiffmann, D. (1999). Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblasts caused by ochratoxin A. Food Chem. Toxicol. 37, 713-721.
10. EFSA. (2006). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to ochratoxin A in food, EFSA-Q-2005-154. EFSA J. 365, 1-56.
11. Hoehler, D., Marquardt, R. R., McIntosh, A. R., and Xiao, H. (1996). Free radical generation as induced by ochratoxin A and its analogs in bacteria (Bacillus brevis).J. Biol. Chem. 271, 27388-27394.
12. JECFA. (2001). Safety Evaluation of Certain Mycotoxins in Food. Fifty-Sixth Meeting of the JOINT FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series No. 47, 281-415. WHO, Geneva.
13. Jones, H. B., Eldridge, S. R., Butterworth, B. E., and Foster, J. R. (1996). Measures of cell replication in risk/safety assessment of xenobiotic-induced, nongenotoxic carcinogenesis. Regul. Toxicol. Pharmacol. 23, 117-127.
14. Kamp, H. G., Eisenbrand, G., Janzowski, C., Kiossev, J., Latendresse, J. R., Schlatter, J., and Turesky, R. J. (2005). Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol. Nutr. Food Res. 49, 1160-1167.
15. Khan, S., Martin, M., Bartsch, H., and Rahimtula, A. D. (1989). Perturbation of liver microsomal calcium homeostasis by ochratoxin A. Biochem. Pharmacol. 38, 67-72.
16. Klaunig, J. E., Kamendulis, L. M., and Xu, Y. (2000). Epigenetic mechanisms of chemical carcinogenesis. Hum. Exp. Toxicol. 19 543-555.
17. Krogh, P., Gyrd-Hansen, N., Hald, B., Larsen, S., Nielsen, J. P., Smith, M., Ivanoff, C., and Meisner, H. (1988). Renal enzyme activities in experimental ochratoxin A-induced porcine nephropathy: Diagnostic potential of phosphoenolpyruvate carboxykinase and gamma-glutamyl transpeptidase activity. J. Toxicol. Environ. Health 23, 1-14.
18. Lock, E. A., and Hard, G. C. (2004). Chemically induced renal tubule tumors in the laboratory rat and mouse: Review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit. Rev. Toxicol. 34, 211-299.
19. Lock, E. A., and Reed, C. J. (2006). Trichloroethylene: Mechanisms of renal toxicity and renal cancer and relevance to risk assessment. Toxicol. Sci. 91, 313-331.
20. Luhe, A., Hildebrand, H., Bach, U., Dingermann, T., and Ahr, H. J. (2003). A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: Expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 73, 315-328.
21. Lutz, U., Lugli, S., Bitsch, A., Schlatter, J., and Lutz, W. K. (1997). Dose response for the stimulation of cell division by caffeic acid in forestomach and kidney of the male F344 rat. Fundam Appl Toxicol. 39, 131-137.
22. Lutz, W. K. (1990). Dose-response relationship and low dose extrapolation in chemical carcinogenesis. Carcinogenesis 11, 1243-1247.
23. Maaroufi, K., Zakhama, A., Baudrimont, I., Achour, A., Abid, S., Ellouz, F., Dhouib, S., Creppy, E. E., and Bacha, H. (1999). Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum. Exp. Toxicol. 18, 410-415.
24. Mally, A., Decker, M., Bekteshi, M., and Dekant, W. (2006a). Ochratoxin A alters cell adhesion and gap junction intercellular communication in MDCK cells. Toxicology 223, 15-25.
25. Mally, A., Pepe, G., Ravoori, S., Fiore, M., Gupta, R. C., Dekant, W., and Mosesso, P. (2005a). Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 18, 1253-1261.
26. Mally, A., Volkel,W., Amberg, A., Kurz, M.,Wanek, P., Eder, E., Hard, G., and Dekant, W. (2005b). Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Chem. Res. Toxicol. 18, 1242-1252.
27. Mally, A., Walker, C. L., Everitt, J. I., Dekant, W., and Vamvakas, S. (2006b). Analysis of renal cell transformation following exposure to trichloroethene in vivo and its metabolite S-(dichlorovinyl)-l-cysteine in vitro. Toxicology. 224, 108-118.
28. Marin-Kuan, M., Nestler, S., Verguet, C., Bezencon, C., Piguet, D., Mansourian, R., Holzwarth, J., Grigorov, M., Delatour, T., Mantle, P., et al. (2006). A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol. Sci. 89, 120-134.
29. Munaron, L., Antoniotti, S., and Lovisolo, D. (2004). Intracellular calcium signals and control of cell proliferation: How many mechanisms? J. Cell. Mol. Med. 8, 161-168.
30. NTP. (1989). Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358, 1-142.
31. Prescott-Mathews, J. S., Wolf, D. C., Wong, B. A., and Borghoff, S. J. (1997). Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats. Toxicol. Appl. Pharmacol. 143, 301-314.
32. Rached, E., Pfeiffer, E., Dekant, W., and Mally, A. (2006). Ochratoxin A: Apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol. Sci. 92, 78-86.
33. Rasonyi, T., Schlatter, J., and Dietrich, D. R. (1999). The role of alpha2uglobulin in ochratoxin A induced renal toxicity and tumors in F344 rats. Toxicol. Lett. 104, 83-92.
34. Santella, L., Ercolano, E., and Nusco, G. A. (2005). The cell cycle: A new entry in the field of Ca2+ signaling. Cell. Mol. Life Sci. 62, 2405-2413.
35. Schilter, B., Marin-Kuan, M., Delatour, T., Nestler, S., Mantle, P., and Cavin, C. (2005). Ochratoxin A: Potential epigenetic mechanisms of toxicity and carcinogenicity. Food Addit. Contam. 22(Suppl. 1), 88-93.
36. SCOOP. (2002). Reports on Tasks for Scientific Cooperation: Assessment of Dietary Intake of Ochratoxin A by the Population of EU Member States. Directorate-General Health and Consumer Protection. Available at: http://ec.europa.eu/food/fs/scoop/3.2.7_en.pdf. Accessed March 16, 2007.
37. Steyn, P. S., Vleggaar, R., Du Preez, N. P., Blyth, A. A., and Seegers, J. C. (1975). The in vitro toxicity of analogs of ochratoxin A in monkey kidney epithelial cells. Toxicol. Appl. Pharmacol. 32, 198-203.
38. Storchova, Z., and Pellman, D. (2004). From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell. Biol. 5, 45-54.
39. Templin,M. V., Larson, J. L., Butterworth, B. E., Jamison, K. C., Leininger, J. R., Mery, S., Morgan, K. T., Wong, B. A., and Wolf, D. C. (1996). A 90-day chloroform inhalation study in F-344 rats: Profile of toxicity and relevance to cancer studies. Fundam. Appl. Toxicol. 32, 109-125.
40. Zepnik, H., Volkel, W., and Dekant, W. (2003). Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 192, 36-44.